tiprankstipranks

GC Corp. Insider Profile

4 Followers
GC Corp., Ten Percent Owner at Artiva Biotherapeutics, Inc., holds 4.57M shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV).
tipranks
GC Corp.

GC Corp.
Artiva Biotherapeutics, Inc. (ARTV)
Ten Percent Owner

Not Ranked
GC Corp. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$51M
100.00%
A breakdown of GC Corp.'s holdings

Insider Roles

Artiva Biotherapeutics, Inc.
(ARTV)
Ten Percent Owner
Roles that GC Corp. holds in companies

Most Profitable Insider Trade

Stock:
Artiva Biotherapeutics, Inc.
(ARTV)
Rating:Informative Buy
Date:Jul 22, 2024 - Today
Return:-5.60%
The most profitable trade made by GC Corp.

GC Corp.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Artiva Biotherapeutics, Inc.
Jul 22, 2024
Ten Percent Owner
Uninformative Buy
5.61M
$50.74M
Success Rate for
ARTV
0 out of 1 profitable transactions on
ARTV
0%
Average Return for
ARTV
Average return per transaction on
ARTV
-5.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 22, 2024
Uninformative Buy
$5.61M
-
$0.00
Jul 22, 2024
Informative Buy
$25.00M
-
$12.00
-5.60%
List of latest transactions for each holding click on a transaction to see GC Corp.'s performance on stock

GC Corp. insider profile FAQ

What is the percentage of profitable transactions made by GC Corp.?
The percentage of profitable transactions made by GC Corp. is ―.
    What is the average return per transaction made by GC Corp.?
    The average return per transaction made by GC Corp. is ―.
      What stocks does GC Corp. hold?
      GC Corp. holds: ARTV stocks.
        What was GC Corp.’s latest transaction?
        GC Corp. latest transaction was an Uninformative Buy of $5.61M.
          What was GC Corp.'s most profitable transaction?
          GC Corp.’s most profitable transaction was an Informative Buy of ARTV stock on July 22, 2024. The return on the trade was -5.60%.
            What is GC Corp.'s role in Artiva Biotherapeutics, Inc.?
            GC Corp.'s role in Artiva Biotherapeutics, Inc. is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.